GATA2 deficiency with susceptibility to MDS/AML: genes and variants
Explore variant evidence for GATA2 deficiency with susceptibility to MDS/AML across 1 analyzed protein (GATA2). Linked ClinVar records include 32 pathogenic or likely pathogenic variants, 8 variants of uncertain significance and 10 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to GATA2 deficiency with susceptibility to MDS/AML
GATA2: Endothelial transcription factor GATA-2
It maintains hematopoietic stem and progenitor cells and directs development of monocytes, dendritic cells, NK cells, and other blood lineages. Haploinsufficiency causes GATA2 deficiency with immunodeficiency, cytopenias, and high risk of myelodysplastic syndrome or AML.
32 ClinVar pathogenic / likely pathogenic and 18 uncertain variants in GATA2 have source records linked to GATA2 deficiency with susceptibility to MDS/AML. Association strength is not clinical gene validity.
Where GATA2 deficiency with susceptibility to MDS/AML variants cluster
- GATA2 GATA-type 2 (positions 349–373): 19 of 32 ClinVar pathogenic / likely pathogenic variants, 11.4× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to GATA2 deficiency with susceptibility to MDS/AML
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| GATA2 T354M | 354 | GATA-type 2 | Pathogenic / likely pathogenic (★★) |
| GATA2 R361C | 361 | GATA-type 2 | Pathogenic / likely pathogenic (★★) |
| GATA2 R398Q | 398 | Pathogenic / likely pathogenic (★★) | |
| GATA2 R398W | 398 | Pathogenic / likely pathogenic (★★) | |
| GATA2 C349R | 349 | GATA-type 2 | Pathogenic / likely pathogenic (★★) |
| GATA2 C352G | 352 | GATA-type 2 | Pathogenic / likely pathogenic (★★) |
| GATA2 C352R | 352 | GATA-type 2 | Pathogenic / likely pathogenic (★★) |
| GATA2 R361G | 361 | GATA-type 2 | Pathogenic / likely pathogenic (★★) |
| GATA2 C373R | 373 | GATA-type 2 | Pathogenic / likely pathogenic (★★) |
| GATA2 L375F | 375 | Pathogenic / likely pathogenic (★★) | |
| GATA2 R396W | 396 | Pathogenic / likely pathogenic (★★) | |
| GATA2 R396L | 396 | Pathogenic / likely pathogenic (★★) | |
| GATA2 R396Q | 396 | Pathogenic / likely pathogenic (★★) | |
| GATA2 R362P | 362 | GATA-type 2 | Pathogenic / likely pathogenic (★★) |
| GATA2 N371K | 371 | GATA-type 2 | Pathogenic / likely pathogenic (★★) |
| GATA2 Y377D | 377 | Pathogenic / likely pathogenic (★★) | |
| GATA2 T354R | 354 | GATA-type 2 | Pathogenic / likely pathogenic (★) |
| GATA2 C349F | 349 | GATA-type 2 | Pathogenic / likely pathogenic (★) |
| GATA2 C349G | 349 | GATA-type 2 | Pathogenic / likely pathogenic (★) |
| GATA2 C352F | 352 | GATA-type 2 | Pathogenic / likely pathogenic (★) |
| GATA2 T354P | 354 | GATA-type 2 | Pathogenic / likely pathogenic (★) |
| GATA2 R361L | 361 | GATA-type 2 | Pathogenic / likely pathogenic (★) |
| GATA2 C373Y | 373 | GATA-type 2 | Pathogenic / likely pathogenic (★) |
| GATA2 L375V | 375 | Pathogenic / likely pathogenic (★) | |
| GATA2 T358N | 358 | GATA-type 2 | Pathogenic / likely pathogenic (★) |
| GATA2 W360L | 360 | GATA-type 2 | Pathogenic / likely pathogenic (★) |
| GATA2 C370W | 370 | GATA-type 2 | Pathogenic / likely pathogenic (★) |
| GATA2 L315P | 315 | GATA-type 1 | Pathogenic / likely pathogenic (★) |
| GATA2 A318T | 318 | GATA-type 1 | Pathogenic / likely pathogenic (★) |
| GATA2 P385Q | 385 | Pathogenic / likely pathogenic (★) | |
| GATA2 M388T | 388 | Pathogenic / likely pathogenic (★) | |
| GATA2 S447R | 447 | Pathogenic / likely pathogenic (★) |
Uncertain variants prioritized for review in GATA2 deficiency with susceptibility to MDS/AML
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| GATA2 M388V | 388 | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; M388T at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.966 | |
| GATA2 W360R | 360 | GATA-type 2 | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; W360L at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| GATA2 R361H | 361 | GATA-type 2 | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; R361G at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
Which prediction tools work for GATA2 deficiency with susceptibility to MDS/AML
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 100 out of 100
- ESM1b (LLR): 100 out of 100
- SIFT: 99 out of 100
- PolyPhen-2: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Monocytopenia with susceptibility to infections also has ClinVar records linked to GATA2 variants; they fall in the same places as the GATA2 deficiency with susceptibility to MDS/AML variants (12 pathogenic / likely pathogenic).
Diseases related to GATA2 deficiency with susceptibility to MDS/AML
- Deafness-lymphedema-leukemia syndrome, also linked to GATA2
- Acute myeloid leukemia, also linked to GATA2
- Monocytopenia with susceptibility to infections, also linked to GATA2
Frequently asked questions
Which genes have records linked to GATA2 deficiency with susceptibility to MDS/AML?
This view contains 1 analyzed proteins: GATA2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 32 pathogenic or likely pathogenic variants, 8 variants of uncertain significance and 10 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 3 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 61 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center